eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
1/2021
vol. 8
 
Share:
Share:
abstract:
Review paper

Asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome and the risk of severe COVID-19

Klaudia Waszczykowska
1
,
Marta Węgierska
1
,
Roxana Drygała
1
,
Rafał Pawliczak
1

  1. Department of Immunopathology, Medical Faculty, Medical University of Lodz, Lodz, Poland
Alergologia Polska – Polish Journal of Allergology 2021; 8, 1: 21–30
Online publish date: 2021/03/23
View full text Get citation
 
PlumX metrics:
Asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome (ACOS) significantly affect the patient’s respiratory system, which requires individualised treatment and professional control. During the SARS-CoV-2 pandemic, all respiratory diseases were taken into consideration as risk factors for severe COVID-19. ACE2 and TMPRSS2 genes, which are crucial for SARS-CoV-2 to enter the host cell, have different expression in the occurrence of asthma or COPD. Also, comparing the severity and mortality of patients with coexistence of asthma or COPD and COVID-19, only COPD patients had worse outcomes of COVID-19, and their mortality was significantly higher. Although ACOS is also a potential risk factor for hospitalisation and mortality in COVID-19 patients, the condition still requires further studies. This overview presents the current state of knowledge on the relationship between the diseases mentioned above and COVID-19.
keywords:

bronchial asthma, chronic obstructive pulmonary disease (COPD), asthma-COPD overlap syndrome, COVID-19, SARS-CoV-2



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.